Black Diamond Therapeutics Inc (BDTX)

Finanzdaten der Black Diamond Therapeutics Inc-Aktie (BDTX)

*Alle Zahlen in Millionen

Enddatum des Zeitraums	2026-06-30	2026-03-31	2025-12-31	2025-09-30	2025-06-30
Periodenlänge	3 Monate	3 Monate	3 Monate	3 Monate	3 Monate
Revenues	-	-	-	-	-
	7.09%12.06	11.26	17.61	10.98	13.42
Research and Development	5.57%7.39	7.00	6.30	7.44	9.32
Operating Income/Loss	7.09%-12.06	-11.26	-17.61	-10.98	-13.42
Nonoperating Income/Loss	3.19%2.15	2.22	2.49	2.48	2.86
	9.62%-9.91	-9.04	-15.12	-8.50	-10.56
Attributable To Parent	9.62%-9.91	-9.04	-15.12	-8.50	-10.56
Basic Average Shares	0.23%57.37	57.23	-	56.93	56.80
Diluted Average Shares	0.23%57.37	57.23	-	56.93	56.80
Basic Earnings Per Share	6.25%-0.17	-0.16	-	-0.15	-0.19
Diluted Earnings Per Share	6.25%-0.17	-0.16	-	-0.15	-0.19